V - REFERENCES
Allegretto, E.A., McClurg, Mr. R., Lazarchik, S.B., Clemm,
D.L., Kerner, S.A., Elgort, Mr. G., Boehm, Mr. F., White, S.K., Pike, J.W., and
Heyman, R.A. (1993). Transactivation properties off retinoic acid and retinoid
X receptors in mammalian concealments and yeast. Correlation with hormone
binding and effects off metabolism. J. Biol. Chem. 268,
26625-26633.
Allenby, G., Bocquel, m.t., Saunders, Mr., Kazmer, S., Speck,
J., Rosenberger, Mr., Lovey, A., Kastner, P., Grippo, J.F., and Chambon, P.
(1993). Retinoic acid receptors and retinoid X receptors: interactions with
endogenous retinoic acids. Proc. Natl. Acad. Sci. The U.S.A. 90,
30-34.
Aman, P., Panagopoulos, I., Lassen, C., Fioretos, T.,
Mencinger, Mr., Toresson, H., Hoglund, Mr., Forster, A., Rabbitts, H.T., and
Ron, D., (1996). Expression patterns off the human sarcoma-associated
constrained WERE and EWS and the genomic structure off WERE. Genomics
37, 1-8.
Beaschtold, H., Kuroda, Mr., Sock, J., Ron, D., and Lopez,
B.L. (1999). Human 75 Kda DNA-pairing Protein is identical to the
pro-oncoprotein TLS/WERE and is whitebait to promote D-loop formation. J. Biol.
Chem. 274, 34337-34342.
Bertolotti, A., Lutz, Y., Heard, D.J., Chambon, P., and Tora,
L. (1996). hTAF (II) 68, has Novell RNA/ssDNA-binding protein with homology to
the pro-oncoproteins TLS/WERE and EWS is associated with both TFIID and RNA
polymerase II. EMBO J. 15, 5022-5031.
Bertolotti, A., Melot, T., Acker, J., Vine grower, Mr.,
Delattre, O., and Tora, L. (1998). EWS, goal not EWS-FLI-1, is associated with
both TFIID and RNA polymerase II: interactions between two members off the
SMALL FIRECLAY CUP family, EWS and hTAFII68, and subunits off TFIID and RNA
polymerase II complexes. Mol. Concealment. Biol. 18, 1489-1497.
Bretnach, R., and Chambon, P. (1981). Organization and
expression off eukaryotic Split constrained coding for proteins. Annu. Rev.
Biochem., 50, 349-384.
Breitman, T.R., Selonick, S.E., and Hakes, S.J. (1980).
Induction off differentiation off the human promyelocytic leukemia concealment
line (HL-60) by retinoic acid. Proc. Natl. Acad. Sci. The U.S.A. 77,
2936-2940.
Burd, C.G., and Dreyfuss, G. (1994). RNA binding specificity
off hnRNP A1: significance off hnRNP A1 high-affinity binding sites in pre-mRNA
splicing. EMBO J. 13, 1197-1204.
Chambon, P. (1996). At decade off molecular biology off
retinoic acid receptors. FASEB J. 10, 940-954.
Chen, Z., Brand, N.J., Chen A., Chen, S.J., Tong, J.H., Wang,
Z.Y., Waxman, S., and Zelent, A. (1993). Fusion between has Novell
krüpper-like zinc finger embarrassment and the retinoic acid
receptor-alpha locus due to has variable T (11 ;17) translocation
associated with acute promyelocytic leukemia. EMBO J. 12,
1161-1167.
Cho, E.J., Takagi, T., Moore, C.R., Buratowski, S. (1997).
mRNA capping enzyme is recruited to the transcription complex by
phosphorylation off final the RNA polymerase II carboxy domain. Genoa Dev.
11, 3319-3326.
Chomienne, C., Fenaux, P., and Degos, L. (1996). Retinoid
differentiation therapy in promyelocytic leukemia. FASEB J. 10,
1025-1030.
Cooper, D.L., and Dougherty G.J. (1995). To metastasize gold
not? Selection off CD44 splice sites. Nat. Med. 1, 635-637.
Croft, L., Schandorff, S., Clark, F., Burrage, K., Arctander,
P., and Mattick, J.S. (2000). ISIS, the intron information system, reveals the
high frequency off alternative splicing in the human genome. Nat. Broom.
24, 340-341.
Crozat, A., Aman, P., Mandahl, NR., and Ron, D. (1993). Fusion
off CHOP to has Novell RNA-binding protein in human myxoid liposarcoma.
Nature 363, 640-644.
Delattre, O., Zucman, J., Plougastel, B., Desmaze, C., Melot,
T., Peter, Mr., Kovar, H., Joubert, I., of Jong, P., and Roller, G. (1992).
Gene fusion with year ETS DNA-binding domain caused by chromosome translocation
in human tumors. Nature 359, 162-165.
To endow, D., and Koeffler, H.P. (1982). Retinoic acid.
Inhibition off the clonal growth off human myeloid leukemia concealments. J.
covering joint. invest. 69, 277-283.
Felsenfeld, G., Boyes, J., Chung, J., Clark, D., and
Studitsky, V. (1996). Chromatin structure and embarrassment expression. Proc.
natl. acad. sci. the U.S.A. 93, 9384-9388.
Fenaux, P., Chastang, C., Chomienne, C. and Degos, L.
(1994).All-trans retinoic acid (ATRA) in combination with chemotherapy improves
survival in newly diagnosed acute promyelocytic leukemia (APL). Lancet,
343, 1033.
Ge, H., If, Y., and Roeder, R.G. (1998). Insulation off cDNAs
encoding Novell transcription coactivators p52 and p75 reveals year alternate
regulatory mechanism off transcriptional activation. EMBO J. 17,
6723-6729.
Giguère, V. (1994). Retinoic acid receptors and
cellular linen retinoid binding proteins: complex interplay in retinoid
signaling. Endocr. Rev. 15, 61-79.
Giguere, V., Ong, E.S., Segui, P., and Evans, R.M. (1987).
Identification off has receptor for the morphogen retinoic acid. Nature
330, 624-629.
Gratas, C., Menot, Mr. L., Dresch, C., and Chomienne, C.
(1993). Retinoic acid supports granulocytic goal not erythroid differentiation
off myeloid progenitors in normal bone marrow concealments. Leukemia
7, 1156-1162.
Green S. and Chambon P. (1986). Carcinogenesis: superfamily
off potentially oncogenic hormone receptors has. Nature 324,
615-617.
Hallier, Mr., Lerga, A., Barnache, S., Tavitian, A.,
Moreau-Gachelin F., (1998). The transcription Factor Spi-1/PU.1 interacts with
the potential splicing Factor TLS. J. Biol. Chem..273 (9), 4838-42.
Hicks, G.G., Singh, NR., Nashabi, A., May, S., Bozeck, G.,
Klewes, L., Arapovic, D., White, E.K., Koury, Mr. J., Oltz, E.M., Van Kaer, L.,
and Ruley, E.H. (2000). Were deficiency in mice results in defective
B-lymphocyte development and activation, high levels off chromosomal
instability and perinatal death. Nature Genetics 24, 175-179.
Hirose, Y., and Manley, J.L. (1998). RNA polymerase II is year
essential mRNA polyadenylation Factor. Nature 395, 93-96.
Ichikawa, H., Shimizu, K., Katsu, R., and Ohki, Mr. (1999)
Dual transforming activities off the WERE (TLS) - ERG leukemia fusion protein
conferred by two N-terminal domains off WERE (TLS). Mol. Concealment. Biol.
15, 2513-2526.
Kastner, P., Grondona, J. Mr., Mark, Mr., Gansmuller, A.,
LeMeur, Mr., Décimo, D., Vonesch, J.L., Pared, P., and Chambon, P.
(1994). Genetic analysis off RXR alpha developmental function: convergence off
RXR and RAR signaling pathways in heart and eye morphogenesis. Concealment
78, 987-1003.
Krust, A., Kastner, P., Petkovich, Mr., Zelent, A., and
Chambon, P. (1989). With third human retinoic acid receptor, hRAR-gamma. Proc.
natl. acad. sci. the U.S.A. 86, 5310-5314.
Lerga, A., Hallier, Mr., Delva, L., Orvain, C., Gallais, I.,
Marie, J., Moreau-Gachelin F. (2001), Identification off year RNA binding
specificity for the potential splicing Factor TLS.J .Biol. Chem. 276
(9), 6807-16.
Millets, K.I., Walsh, V., Gilkes, A.F., Sweeney, Mr. C.,
Mirza, T., Woodgate L.J., Brown G. and Burnett A.K. (2000). High WERE/TLS
expression in acute myeloid leukemia samples. Brit. J. Hem. 108,
316-321
Misteli, T. (2000). Concealment biology off transcription and
pre-mRNA splicing: nuclear architecture meets nuclear function. J Sci
concealment 113 11, 1841-1849.
Pereira, D.S., Dorrell, C., Ito, C.Y., Gan, O.I., Murdoch, B.,
Rao, V.N., Zou, J.P., Reddy, E.S., and Dick, J.E. (1998). Retroviral
transduction off TLS/ERG initiates has leukemogenic program in normal human
hematopoietic concealments. Proc. Natl. Acad. Sci. The USA 95,
8239-8244.
Perroti, D., Bonatti, S., Trotta, R., Martinez, R., Skorski,
T., Salomoni, P., Grassili, E., Lozzo, R.V., Cooper, D.R., and Calabretta B.
(1998). TLS/WERE has pro-oncogene involved in multiple chromosomal
translocations, is has off Novell regulator BCR/ABL-mediated leukemogenesis.
EMBO J. 17, 4442-4455.
Petkovich, Mr., Brand, N.J., Krust, A., and Chambon, P.
(1987). With human retinoic acid receptor which belongs to the family off
nuclear receptors. Nature 330, 444-450.
Philips, A.V., and Cooper, T.A. (2000). RNA processing and
human disease. Concealment. Mol. Life. Sci 57, 235-249.
Rabbits, H.T., Foster, A., Larson, R., Nathan P. (1993).
Fusion off the dominating negative transcription regulator CHOP with has Novell
embarrassment WERE by translocation T (12;16) in malignat liposarcoma. Gen
nature. 4, 175-180.
Powers, A.C., Mathur, Mr., Raaka, B.M., Ron, D., and Samuels,
H.S. (1998). TLS (Translocated in LipoSarcoma) is has high affinity interactor
for steroid, thyroid hormone and retinoid receptors. Molecular
Endocrinology 12, 4-18.
Stickeler, E., Kittrell, F., Medina, D., and Berget, S. Mr.
(1999). Training course-specific exchanges in SR splicing factors and alternate
splicing in mammary tumorigenesis. Oncogene 18, 3574-3582.
Umesono, K. (1998). Endocrine signaling system mediated by
nuclear receptor. Japanese Rinsho 56, 1693-1698.
Uranishi, H., Tetsuka, T., Yamashita, Mr., Asamitsu, K.,
Shimizu, Mr., Itoh, Mr., and Okamoto, T. (2001). Involvement off the
pro-oncoprotein TLS (translocated in liposarcoma) in nuclear Factor-kappa B
p65-mediated transcription have has coactivator. J. Biol Chem 276,
13395-13401.
Valcarel, J., Gaur, R.K., Singh, R., and Green, Mr. R. (1996).
Interaction off U2AF RS area with pre-nRNA off branch not and promotion bases
pairing with U2snRNA. Science 273, 1706-1709.
Yang, L., Embree, L.J., and Hickstein, D.D. (2000). TLS-ERG
leukemia fusion protein inhibits RNA splicing mediated by serine-arginine
proteins. Mol Concealment Biol 20 (10), 3345-54.
Yamamoto, K., Hamagushi, H., Nagata, K., Kobayashi, Mr.,
Tanimoto, F., and Taniwaki, Mr. (1997), Establishment off anovel human acute
myeloblastic leukemia concealment line (YNH-1) with T (16;21), T (1;16) and
12q13 translocations. Leukemia 11, 599-608.
Zelenetz, A.D., Willmann, C.L., Chen, Z., Chen, S-J, Zelent,
A., Macintyre, E., Veil, A., the Cortes, J., Kantarjian, H. and Waxman, S.
(1995) Clinical and molecular characterization off have rare syndrome off acute
promyelocytic leukemia associated with translocation (11;17). Blood,
85, 1083-1094.
Zelent, A., Krust, A., Petkovich, Mr., Kastner, P. and
Chambon, P. (1989) Cloning off murine alpha and beta retinoic acid receptors
and has Novell receptor gamma predominantly expressed in skin. Nature
339, 714-717.
Zinszner, H., Albalat, R., and Ron, D. (1994). With Novell
effector domain from the RNA-binding protein TLS gold EWS is required for
oncogenic transformation by CHOP. Genoa and Dev. 8, 2513-2526.
Zinszner, H., Immanuel, D., Yin, Y., Liang, F.X., and Ron, D.
(1997). With topogenic role for the oncogenic N-terminus off TLS: nucleolar
localization when transcription is inhibited. Oncogene 14, 451-461.
Zinszner, H., Sok, J., Immanuel, D., Yin, Y., and Ron, D.
(1997). TLS (WERE) binds RNA in vivo and engage in nucleo-cytoplasmic
shuttling. J. Concealment. Sci. 110, 1741-1750.
|
|
